Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
Investigational New Drugs|September 14, 2011
Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitorsYoshihiko Fujita, Rafiqul Islam, Kazuko Sakai, et al.Plos One|January 14, 2012
SRPX2 is a novel chondroitin sulfate proteoglycan that is overexpressed in gastrointestinal cancerKaoru Tanaka, Tokuzo Arao, Daisuke Tamura, et al.Cancer Science|November 1, 2011
Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cellsKazuyuki Furuta, Tokuzo Arao, Kazuko Sakai, et al.Gynecologic Oncology|August 30, 2017
Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancerKazue Takahashi, Naoki Sato, Tae Sugawara, et al.Anticancer Research|February 4, 2019
Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung CancerMasahiro Katsurada, Tatsuya Nagano, Motoko Tachihara, et al.Cancer Research|February 11, 2010
FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growthHiroyasu Kaneda, Tokuzo Arao, Kaoru Tanaka, et al.Cell Structure and Function|July 16, 2011
Characterization of YIPF3 and YIPF4, cis-Golgi Localizing Yip domain family proteinsKouji Tanimoto, Kurumi Suzuki, Eija Jokitalo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2010
Antitumor activity of BIBF 1120, a triple angiokinase inhibitor, and use of VEGFR2+pTyr+ peripheral blood leukocytes as a pharmacodynamic biomarker in vivoKanae Kudo, Tokuzo Arao, Kaoru Tanaka, et al.Cancer Management and Research|February 27, 2020
Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLCNaoko Katsurada, Motoko Tachihara, Yukihisa Hatakeyama, et al.Journal of Neuromuscular Diseases|January 7, 2026
Characteristics of early-onset, rapidly progressive scoliosis in spinal muscular atrophy type I treated with disease-modifying therapy -a multicenter retrospective study conducted in JapanTomokazu Kimizu, Reiko Arakawa, Mikiko Hasegawa, et al.Pageof 11